Vitamin D Level is Associated with Severity of Coronary Artery Atherosclerosis and Incidence of Acute Coronary Syndromes in Non-diabetic Cardiac Patients

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2019 Mar 23

PMID 30899288

Citations 19

Authors

Ewelina A Dziedzic

Jakub S Gasior

Mariusz Pawlowski

Beata Wodejko-Kucharska

Tomasz Saniewski

Anna Marcisz

Marek J Dabrowski

Affiliations

Soon will be listed here.

Abstract

Introduction: Ischaemic heart disease is the main cause of death in developed countries. There are many modifiable risk factors associated with coronary heart disease (CAD). A growing number of studies point to vitamin D deficiency as a risk factor for heart attacks and the conditions associated with cardiovascular disease. This study aimed to analyse the relationship between the level of 25-hydroxyvitamin D (25(OH)D) and the severity of coronary artery atherosclerosis and to study 25(OH)D levels in non-diabetic patients hospitalised due to acute coronary syndrome and those diagnosed with stable CAD.

Material And Methods: oronary angiography was performed prospectively in 410 successive cardiac patients. The severity of coronary artery atherosclerosis was assessed according to the Coronary Artery Surgery Study Score (CASSS). The plasma 25(OH)D level was assessed with the electrochemiluminescence method.

Results: The 25(OH)D level proved to be one of the significant determinants of the CASSS ( < 0.05). In subjects without significant lesions in the coronary arteries the 25(OH)D level was significantly higher compared to patients with one- to three-vessel coronary atherosclerosis ( < 0.05). A significantly higher 25(OH)D level was noted in patients diagnosed with stable CAD compared to patients hospitalised due to acute coronary syndrome ( < 0.01).

Conclusions: Patients with one- to three-vessel atherosclerosis have a significantly lower 25(OH)D level compared to patients without significant lesions in the coronary arteries. A lower 25(OH)D level was observed in patients hospitalised due to acute coronary syndrome compared to patients diagnosed with stable CAD.

Citing Articles

Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 134000 Individuals in 29 Randomized Clinical Trials and 157000 Individuals in 30 Prospective Cohort Studies: An Updated Systematic Review and Meta-analysis.

Rasouli M, Darvishzadehdaledari S, Alizadeh Z, Moradi G, Gholami F, Mahmoudian A J Res Health Sci. 2024; 23(4):e00594.

PMID: 38315909 PMC: 10843321. DOI: 10.34172/jrhs.2023.129.

Dietary supplements, nutraceuticals and functional foods use after myocardial infarction depend on the age, sex, BMI and professional activity - a pilot study.

Haponiuk-Skwarlinska J, Antoniak A, Ciurla M, Paluch K, Makulec G, Klimczak-Tomaniak D Int J Occup Med Environ Health. 2023; 36(6):732-743.

PMID: 37811858 PMC: 10743345. DOI: 10.13075/ijomeh.1896.02255.

Exploring the potential of microRNA as a diagnostic tool for gestational diabetes.

Elhag D, Al Khodor S J Transl Med. 2023; 21(1):392.

PMID: 37330548 PMC: 10276491. DOI: 10.1186/s12967-023-04269-2.

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry.

Gil R, Kern A, Pawlowski T, Bil J Arch Med Sci. 2023; 19(2):324-330.

PMID: 37034511 PMC: 10074308. DOI: 10.5114/aoms.2020.92974.

Protective effect of vitamin D on imidacloprid-induced testicular injury in rats.

Keles H, Yalcin A, Aydin H Arch Med Sci. 2022; 18(6):1659-1665.

PMID: 36457972 PMC: 9710272. DOI: 10.5114/aoms.2019.86776.

References

Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R . 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation. 2000; 102(23):2867-72. DOI: 10.1161/01.cir.102.23.2867. View

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

Osborne J, Hutchinson P . Vitamin D and systemic cancer: is this relevant to malignant melanoma?. Br J Dermatol. 2002; 147(2):197-213. DOI: 10.1046/j.1365-2133.2002.04960.x. View

Timms P, Mannan N, Hitman G, Noonan K, Mills P, Syndercombe-Court D . Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM. 2002; 95(12):787-96. DOI: 10.1093/qjmed/95.12.787. View

Xiang W, Kong J, Chen S, Cao L, Qiao G, Zheng W . Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2004; 288(1):E125-32. DOI: 10.1152/ajpendo.00224.2004. View

Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O . 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005; 111(13):1666-71. DOI: 10.1161/01.CIR.0000160353.27927.70. View

Zittermann A, Schleithoff S, Koerfer R . Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005; 94(4):483-92. DOI: 10.1079/bjn20051544. View

Zadshir A, Tareen N, Pan D, Norris K, Martins D . The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. 2005; 15(4 Suppl 5):S5-97-101. View

Ferrario C, Strawn W . Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006; 98(1):121-8. DOI: 10.1016/j.amjcard.2006.01.059. View

10.

Pittas A, Lau J, Hu F, Dawson-Hughes B . The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92(6):2017-29. PMC: 2085234. DOI: 10.1210/jc.2007-0298. View

11.

Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R . Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007; 167(11):1159-65. DOI: 10.1001/archinte.167.11.1159. View

12.

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

13.

Wang T, Pencina M, Booth S, Jacques P, Ingelsson E, Lanier K . Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4):503-11. PMC: 2726624. DOI: 10.1161/CIRCULATIONAHA.107.706127. View

14.

Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D . Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008; 74(2):170-9. DOI: 10.1038/ki.2008.101. View

15.

Yetley E . Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008; 88(2):558S-564S. DOI: 10.1093/ajcn/88.2.558S. View

16.

Melamed M, Michos E, Post W, Astor B . 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008; 168(15):1629-37. PMC: 2677029. DOI: 10.1001/archinte.168.15.1629. View

17.

Chen S, Glenn D, Ni W, Grigsby C, Olsen K, Nishimoto M . Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008; 52(6):1106-12. PMC: 2690395. DOI: 10.1161/HYPERTENSIONAHA.108.119602. View

18.

Giovannucci E . Expanding roles of vitamin D. J Clin Endocrinol Metab. 2009; 94(2):418-20. DOI: 10.1210/jc.2008-2695. View

19.

Oh J, Weng S, Felton S, Bhandare S, Riek A, Butler B . 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009; 120(8):687-98. PMC: 3099646. DOI: 10.1161/CIRCULATIONAHA.109.856070. View

20.

Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M . Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009; 170(8):1032-9. DOI: 10.1093/aje/kwp227. View